This document discusses the role of enteral nutrition therapy in treating pediatric Crohn's disease. It provides a history of enteral therapy and reviews studies showing its effectiveness in inducing remission and improving growth. Enteral therapy is recommended as a first-line induction treatment in other countries but not widely used in the US due to concerns about side effects, compliance and lack of experience. The document outlines the pros and cons of enteral therapy and compares it favorably to steroid treatment, noting its ability to induce remission, improve mucosal healing and linear growth with fewer adverse effects. Unanswered questions remain around optimal protocols and long-term outcomes compared to other medical therapies.